Evidence graft-versus-lymphoma effect allogeneic bone marrow transplantation existence immunologic antileukemia reaction allogeneic bone marrow transplantation BMT similar graft-versus-tumor effect lymphomas results BMT consecutive patients relapsed Hodgkin disease aggressive non-Hodgkin lymphoma patients years age HLA-matched donors allogenic marrow transplants patients purged autologous grafts median age years allogeneic autologous graft recipients patient response conventional salvage therapy transplant factor event-free survival BMT patient response therapy BMT type graft probability relapse BMT actuarial probability relapse patients conventional salvage therapy BMT allogenic BMT autologous BMT actuarial probability event-free survival years patients responsive lymphomas allogeneic autologous transplants beneficial antitumor effect allogeneic BMT transplant-related mortality graft-versus-host disease Allogeneic BMT significant graft-versus-lymphoma effect magnitude effect similar leukemias 